Significant immediate and long-term improvement in quality of life and disease coping in patients with vitiligo after group climatotherapy at the dead sea

Acta Dermato-Venereologica

Volumn 91, Issue 2, 2011, Pages 152-159

  Krüger, Christian ^a,b   Smythe, Jim W ^b   Spencer, Jennifer D ^a,b   Hasse, Sybille ^a,b   Panske, Angela ^a   Chiuchiarelli, Giorgia ^a   Schallreuter, Karin U ^a,b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Coping; Dead sea; Depression; Pseudocatalase pc kus; Quality of life; Vitiligo

Indexed keywords

BETA ENDORPHIN; HYDROCORTISONE;

ADJUSTMENT TO CHRONIC SKIN DISORDERS QUESTIONNAIRE; ADULT; ANXIETY; ARTICLE; AVOIDANCE BEHAVIOR; BECK DEPRESSION INVENTORY; CLIMATOTHERAPY; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; DERMATOLOGY LIFE QUALITY INDEX; FEMALE; HELPLESSNESS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SALIVA; STRESS; TREATMENT OUTCOME; VITILIGO; WELLBEING;

ADAPTATION, PSYCHOLOGICAL; ADULT; ANTIOXIDANTS; ANXIETY; BETA-ENDORPHIN; CATALASE; CLIMATOTHERAPY; COMBINED MODALITY THERAPY; DEPRESSION; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PSYCHOTHERAPY, GROUP; QUALITY OF LIFE; QUESTIONNAIRES; SALIVA; STRESS, PSYCHOLOGICAL; TIME FACTORS; VITILIGO;

EID: 79952399542     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1037     Document Type: Article

References (54)

1. Schallreuter KU, Bahadoran P, Picardo M, Slominski A, Elassiuty YE, Kemp EH, et al. Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol 2008; 17: 139-140; discussion 41-60.
2. Taieb A, Picardo M. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 2007; 20: 27-35.
3. Estrada Castañón R, Torres Bibiano B, Alarcón Hernández H, Villegas Arrizón A, Martínez Sandoval E, Chávez López G, et al. [Cutaneous epidemiology in two sectors of care in Guerrero, México]. Dermatol Rev Mex 1992; 36: 29-34, in Spanish.
4. Howitz J, Brodthagen H, Schwartz M, Thomsen K. Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol 1977; 113: 47-52.
5. Xu YY, Ye DQ, Tong ZC. An epidemiological survey on four skin diseases in Anhui. Chin J Dermatol 2002; 35: 406-407 (in Chinese).
6. Massarrat MS, Tahaghoghi-Mehrizi S. Iranian National Health Survey: a brief report. Arch Iranian Med 2002; 5: 73-79.
7. Ongenae K, Dierckxsens L, Brochez L, Van Geel N, Naeyaert JM. Quality of life and stigmatization profile in a cohort of vitiligo patients and the effect of the use of camouflage. Dermatology 2005; 210: 279-285.
8. Porter J, Beuf AH, Nordlund JJ, Lerner AB. Psychological reaction to chronic skin disorders: a study of patients with vitiligo. Gen Hosp Psychiatry 1979; 1: 73-77.
9. McLeod J. The social experience of individuals living with vitiligo [Dissertation]. Manchester: University of Manchester; 2004.
10. Onunu AN, Kubeyinje EP. Vitiligo in the Nigerian African: a study of 351 patients in Benin City, Nigeria. Int J Dermatol 2003; 42: 800-802.
11. Porter JR, Beuf AH. Racial variation in reaction to physical stigma: a study of degree of disturbance by vitiligo among black and white patients. J Health Soc Behav 1991; 32: 192-204.
12. Porter JR, Beuf AH, Lerner A, Nordlund J. Psychosocial effect of vitiligo: a comparison of vitiligo patients with "normal" control subjects, with psoriasis patients, and with patients with other pigmentary disorders. J Am Acad Dermatol 1986; 15: 220-224.
13. Kent G, Al-Abadie M. Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers. Clin Exp Dermatol 1996; 21: 330-333.
14. Ongenae K, Van Geel N, De Schepper S, Naeyaert JM. Effect of vitiligo on self-reported health-related quality of life. Br J Dermatol. 2005; 152: 1165-1172.
15. Sukan M, Maner F. The problems in sexual functions of vitiligo and chronic urticaria patients. J Sex Marital Ther 2007; 33: 55-64.
16. Porter JR, Beuf AH, Lerner AB, Nordlund JJ. The effect of vitiligo on sexual relationships. J Am Acad Dermatol 1990; 22: 221-222.
17. Salzer BA, Schallreuter KU. Investigation of the personality structure in patients with vitiligo and a possible association with impaired catecholamine metabolism. Dermatology 1995; 190: 109-115.
18. Papadopoulos L, Bor R, Legg C, Hawk JL. Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology. Clin Exp Dermatol 1998; 23: 243-248.
19. Picardi A, Pasquini P, Cattaruzza MS, Gaetano P, Melchi CF, Baliva G, et al. Stressful life events, social support, attachment security and alexithymia in vitiligo. A case-control study. Psychother Psychosom 2003; 72: 150-158.
20. Sampogna F, Raskovic D, Guerra L, Pedicelli C, Tabolli S, Leoni L, et al. Identification of categories at risk for high quality of life impairment in patients with vitiligo. Br J Dermatol 2008; 159: 351-359.
21. Njoo MD, Westerhof W. Therapeutic Guidelines for Vitiligo. In: Lotti TaH, J., editor. Vitiligo: problems and solutions. New York: Marcel Dekker Inc.; 2004, p. 235-251.
22. Greiner D, Ochsendorf FR, Milbradt R. Vitiligo-therapie mit phenylalanin/UV A. Katamnestische untersuchungen nach fünf jahren. Hautarzt 1994; 45: 460-463.
23. Njoo MD, Spuls PI, Bos JD, Westerhof W, Bossuyt PM. Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature. Arch Dermatol 1998; 134: 1532-1540.
24. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000; 42: 245-253.
25. Lotti TM, Menchini G, Andreassi L. UV-B radiation microphototherapy. An elective treatment for segmental vitiligo. J Eur Acad Dermatol Venereol 1999; 13: 102-108.
26. Grimes PE. New insights and new therapies in vitiligo. JAMA 2005; 293: 730-735.
27. Schallreuter KU, Wood JM, Lemke KR, Levenig C. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Dermatology 1995; 190: 223-229.
28. Schallreuter KU, Krüger C, Würfel BA, Panske A, Wood JM. From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo. Int J Dermatol 2008; 47: 743-753.
29. Schallreuter KU, Moore J, Behrens-Williams S, Panske A, Harari M. Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS). Int J Dermatol 2002; 41: 482-487.
30. Lewis V, Finlay AY. 10 years experience of the Dermatology Life Quality Index (DLQI). J Invest Dermatol Symp Proc 2004; 9: 169-180.
31. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
32. Stangier U, Ehlers A, Gieler U. Fragebogen zur Bewältigung von Hautkrankheiten (FBH). Göttingen: Hogrefe; 1996.
33. Stangier U, Ehlers A, Gieler U. Measuring adjustment to chronic skin disorders: validation of a self-report measure. Psychol Assess 2003; 15: 532-549.
34. Mattoo SK, Handa S, Kaur I, Gupta N, Malhotra R. Psychiatric morbidity in vitiligo and psoriasis: a comparative study from India. J Dermatol 2001; 28: 424-432.
35. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
36. Charmandari E, Tsigos C, Chrousos G. Endocrinology of the stress response. Ann Rev Physiol 2005; 67: 259-284.
37. King SL, Hegadoren KM. Stress hormones: how do they measure up? Biol Res Nurs. 2002; 4: 92-103.
38. Parrish JA, White HAD, Pathak MA. Photomedicine. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, editors. Dermatology in General Medicine. New York: McGraw-Hill; 1979, p. 942-994.
39. Chee SN, Rhodes LM, Murrell DF. A comparison of dermatology life quality index (DLQI) scores in a dermatology practice setting. Australasian J Dermatol 2008; 49 (Suppl 1).
40. van Geel N, Ongenae K, Vander Haeghen Y, Vervaet C, Naeyaert JM. Subjective and objective evaluation of noncultured epidermal cellular grafting for repigmenting vitiligo. Dermatology 2006; 213: 23-29.
41. Papadopoulos L, Bor R, Legg C. Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy. Br J Med Psychol 1999; 72: 385-396.
42. KK, editor. The quality of life in elderly patients with psoriasis, vitiligo and eczema. 21st Annual Meeting of ARABMED in Europe; 2004; Istanbul, Turkey: ARABMED.
43. Gajur A, Schäfer I, Augustin M. Versorgungssituation und Bewertung des therapeutischen Nutzens von Patienten mit Vitiligo. J Dtsch Dermatol Gesell 2007; 5 (Suppl 2: Abstraktband 44. Tagung der Deutschen Dermatologischen Gesellschaft): S163.
44. Aghaei S, Sodaifi M, Jafari P, Mazharinia N, Finlay AY. DLQI scores in vitiligo: reliability and validity of the Persian version. BMC Dermatol 2004; 4: 8.
45. Mechri A, Amri M, Douarika AA, Ali Hichem BH, Zouari B, Zili J. Morbidite psychiatrique et qualité de vie des patients atteints du vitiligo: étude cas-témoins. Tunis Med 2006; 84: 632-635.
46. Hartmann A, Lurz C, Hamm H, Brocker EB, Hofmann UB. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo. Int J Dermatol 2005; 44: 736-742.
47. Parsad D, Kanwar AJ. DLQI outcome in vitiligo and its impact on the treatment outcome. Pigment Cell Res [poster abstract] 2006; 19: 512.
48. Al Robaee AA. Assessment of quality of life in Saudi patients with vitiligo in a medical school in Qassim province, Saudi Arabia. Saudi Med J 2007; 28: 1414-1417.
49. Manolache L, Benea V. Stress in patients with alopecia areata and vitiligo. J Eur Acad Dermatol Venereol 2007; 21: 921-928.
50. Belhadjali H, Amri M, Mecheri A, Doarika A, Khorchani H, Youssef M, et al. Vitiligo et qualité de vie: étude castémoins. Ann Dermatol Venereol 2007; 134: 233-236.
51. Schmid-Ott G, Kunsebeck HW, Jecht E, Shimshoni R, Lazaroff I, Schallmayer S, et al. Stigmatization experience, coping and sense of coherence in vitiligo patients. J Eur Acad Dermatol Venereol. 2007; 21: 456-461.
52. Gieler U, Brosig B, Schneider U, Kupfer J, Niemeier V, Stangier U, et al. Vitiligo - coping behavior. Dermatol Psychosom 2000; 1: 6-10.
53. Lee KK, Lee JH, Kim HW, Paik KC, Kim YC. Emotional state and personality characteristics in patients with vitiligo. Korean J Psychosomatic Med 2000; 8: 88-97.
54. Gilchrest BA, Park HY, Eller MS, Yaar M. Mechanisms of ultraviolet light-induced pigmentation. Photochem Photobiol 1996; 63: 1-10.